AUVI is Making a Big Splash with Game-Changing Infection Prevention Tech!

AUVI is Making a Big Splash with Game-Changing Infection Prevention Tech!͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ Greetings All, One thing that has happened because of the pandemic is how seriously we now take the air we breathe. Air can be a scary thing because of pathogens. Airborne diseases are caused by pathogenic microbes small enough to be discharged from an infected person via coughing, sneezing, laughing, and close personal contact or aerosolization of the microbes. One emerging Wall Street company is starting to heed major attention on the NASDAQ for developing and acquiring proprietary infection prevention and control technology. Their motto? Better Air. Better Business. Better Life. Applied UV, Inc. (NASDAQ: AUVI), which trades around $1, is on a mission to rapidly build a scientific-based pathogen elimination platform that is safe, effective, simple and protects businesses, facilities and people around the globe. This rising company has a massively growing market. The global [air purifier market]( size is expected to reach USD 25.97 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.1% from 2022 to 2030. It should be highlighted that (NASDAQ: AUVI) has a competitive advantage. The company has research-backed, tested and certified portfolio of patented disinfection products. PLUS, products are already used by highly recognized global brands. This includes NASA! One of (NASDAQ: AUVI)’s products, Airocide, demonstrated effective removal of aerosolized SARS CoV-2 virus from the air with a 3.25 log (99.94%) within five minutes and thirty seconds of operation!! A NASA study has found that tests showed as many as 93% of Anthrax spores that enter Airocide are destroyed! The company’s business case is strong, as products are used across multiple verticals from consumer applications to commercial/heavy industrial consumers. Markets include entertainment, sports arenas, public spaces, education, transportation/logistics, agriculture, post-harvest cannabis, food and beverage, winery/dairy, food preservation, government correctional facilities, hospitals, long-term health facilities, and dental offices. Phew… that’s quite a long list of markets offering monstrous revenue potential for (NASDAQ: AUVI). No wonder [American Bulls]( currently has a “STAY LONG” alert on this stock! Keep on reading to discover why Applied UV, Inc. (NASDAQ: AUVI) could be trading at an obscene value right now…. [( NASDAQ: AUVI Applied UV, Inc. (NASDAQ: AUVI) develops and acquires proprietary infection prevention and control technology in the healthcare, commercial & public venue, food processing/storage, cannabis, and education, vertical markets. The company has a tremendous global distribution footprint in 52 countries thus far! AUVI has two wholly owned subsidiaries - SteriLumen, Inc. and Munn Works, LLC. Munn Works manufactures luxury and backlit mirrors, patented - disinfection mirrors utilizing the SteriLumen proprietary PCO technology and conference room & living spaces furnishings, specifically for the hospitality industry. The hospitality segment is enormous and Munn Works already caters to giants like Hyatt, Wynn, Hilton, Holiday Inn, and Four Seasons! The subsidiary has also recently [signed a deal]( to provide furnishings to three major U.S. hotels and condos. According to recent data, worldwide travel and tourism revenues are forecast to reach $716.8 billion this year, representing a 45 percent increase over 2021. With the travel industry coming back, luxury hotels and condos are looking for opportunities to refurbish and capitalize on the increased travel demand. Sterilumen owns and markets a portfolio of products with advanced pathogen elimination technology, branded Airocide® by Sterilumen, Scientific Air™ by Sterilumen, Airoclean™ 420 by Sterilumen, and Lumicide™ by Sterilumen. Leading organizations globally rely on AUVI’s air purification systems to completely eliminate airborne and surface infections, mold, bacteria, allergens and other contaminants. The company’s customers include Kaiser Permanente, NY Health+Hospitals, Baptist Health South Florida, Boston Red Sox’s Fenway Park, JetBlue Park, France’s Palace of Versailles, Invited Clubs, Whole Foods, Del Monte Foods, U.S. Department of Veterans Affairs, and more. NASA used Airocide’s and Airoclean™ 420’s Photocatalytic Oxidation technology to sanitize its International Space Station! Scientifically proven to reduce Healthcare Acquired Infections (HAI), Scientific Air™ offers a proprietary 3-stage technology integrating HEPA filters, ultraviolet germicidal light chamber and active carbon substrate. Scientific Air is Mobile Air Disinfection Used by Leading Healthcare - Laboratory validated 99.99%+ kill rate on viruses, bacteria, mold, odors and VOCS - NO harmful by-products - Rapid, portable, whole-room disinfection via patented 3-phase design (HEPA, UV-C, Carbon) - Proven and tested in facilities with EPA and FDA guideline compliance and trusted by Infection Prevention, Facilities, EHS and EVS Professionals Tested Under EPA Guidelines Even though air cleaning devices don’t have to be registered, the EPA does have guidelines for the appropriate type and size of bio-aerosol chamber in which to test.Scientific Air Management products are tested under these guidelines and have Laboratory tested kill rate of up to 99.9995% of airborne norovirus surrogate (one of the most difficult viruses to kill) and 99.9999% of bacterial surrogate including TB and C-diff representative pathogens! View evidence [HERE.]( Airocide is Air Disinfection Used Globally - Developed for NASA to provide safe, clean air - Destroys 99.99% of airborne bacteria, mold, fungi & viruses - Advanced bioconversion technology uses photocatalytic oxidation to fully destroy airborne bacteria, mold, fungi, viruses, volatile organic compounds, VOC’s, & odors - ZERO harmful by-products while in use with people present - FDA Listed Medical Device (Class II) suitable for providing medical grade air purification in critical hospital settings UV Disinfection Market: Compelling Growth Drivers The global air purifier market size is set to grow exponentially as technology continues to improve and focus on stopping the spread of contagious diseases. - Scientists Globally advocating Improving Air Quality post-pandemic significantly boosting global adoption to control airborne pathogen transmission - Governments Globally mandating health agencies to address air quality via grants and mechanisms to ease visitation and protect facilities against future pathogens - Mar 2022 – White House, US Federal EPA Ventilation Guidelines set new “clean air” standard - The company's compelling merits: low capital, operating and maintenance costs, convenient installation, and faster contact time - Increasing adoption of pathogen disinfection across an array of verticals - CDC states 1 in 25 Patients have at least 1 Hospital Acquired Infection (HAI) annually - CDC states 3M serious infections occur every year in LTC More Competitive Advantages - AUVI is one of the only research-backed, clinically-proven air and surface disinfection technology companies with international distribution and globally recognized end users with product developed for NASA - AUVI air disinfection portfolio utilizes advanced, patented PCO and advanced UVC with carbon technologies with no harmful by-products vs. most compelling UVC products - Highly fragmented industry; “Me Too” products - Global race fueled by Govt mandates to address antiquated air ventilation and poor air quality - Across multiple high growth verticals - Smart home devices serving as “connected” beacon, validating their business plans Growing Revenues AUVI reported Q3 2022 net sales of $5.9 million representing an increase of 65% (+$2.3m)! The company’s hospitality segment increased $2.5m, primarily as a result of the fulfillment of orders that were delayed from Q2 plus the addition of the orders fulfilled from the VisionMark acquisition. “Looking ahead, we remain optimistic about the new business opportunities for our solutions and expect an acceleration in sales as we introduce new products and market conditions become more favorable for our customers.” - John F. Andrews, Applied UV's Chief Executive Officer The Cannabis Opportunity For over a decade, commercial and home/hobby growers globally have relied on the company’s Airoclean™ 420 Photocatalytic Oxidation technology to completely destroy airborne powdery mildew, fungal diseases, mold, blights and bacteria. Even NASA used Airoclean’s patented technology to sanitize the International Space Station. Airoclean420 is far more effective than HEPA filters’ screen door design, which circulates harmful pathogens back into the air. Unlike harmful fungicides, It is completely safe and green. No emissions. No ozone. No chemicals. "Clean, purified air is critical to cannabis crop yield. Powdery mildew spreads through the air, invades cannabis plants’ vascular system and can wreak havoc on an entire crop. Airoclean™ 420 not only thoroughly removes powdery mildew to boost crop yield, but also protects personnel in cannabis facilities from airborne pathogens. Now, with 40% Off Airoclean, our customers can enjoy a bumper profit." - Max Munn, Applied UV, Inc. President & Director In summary… The pandemic has raised market demand and the value of a wide range of things that so long craved for attention. Air purifiers have become indispensable in our lives over the past few years. According to the United States Environmental Protection Agency, air purifiers can diminish airborne contaminants, which comprise viruses in any confined space. Applied UV, Inc. (NASDAQ: AUVI) is taking on some of the biggest markets, and has some of the biggest clients already. With millions in sales, distribution in over 50 countries, a competitive advantage of clinically proven technology, AND a “STAY LONG” rating, now is the time to have the company on your radar! Start your research now! Copyright 2022 © SCDalerts.com is owned and operated by the owner of SCD Media LLC. Disclaimer and Privacy For more Information please contact info@smallcapsdaily.com This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security. SCD Media, its managers, its employees, affiliates, and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above. To the maximum extent permitted by law, the Company disclaims all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete, or unreliable, or result in any investment or other losses. You received this message as part of your subscription to SCD Alerts. SCD Alerts is a free financial news and information website. We do not directly sell any products or offer any personal financial advice, nor do we advocate the purchase or sale of any security or investment for any specific individual. We also do not make any guarantee or warranty about what is advertised above. If you have questions or concerns about a product you’ve seen in one of our emails, we encourage you to reach out to that company directly. Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by SCD Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “SCD” refers to SCD Media. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here. We do not own any shares in AUVI. We have been currently compensated Five Thousand Dollars Cash ($5,000) via bank wire transfer from a third-party Carebear Marketing LLC for a 3 Day Marketing Program regarding AUVI with a start date of 12/17/2022 to 12/19/2022. SCD has a relationship with the owner of Carebear Marketing LLC who was compensated Fifty-Five Thousand dollars for Marketing Efforts regarding AUVI. SCD’s business model is to receive financial compensation to promote public companies. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, SCD often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. No longer want to receive these emails? [Unsubscribe](. Small Caps Daily 1334 Northampton St Easton, PA 18042